DIVA Laboratories Ltd (4153) - Cash Flow Conversion Efficiency
Based on the latest financial reports, DIVA Laboratories Ltd (4153) has a cash flow conversion efficiency ratio of -0.018x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-16.94 Million ≈ $-533.61K USD) by net assets (NT$936.07 Million ≈ $29.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of DIVA Laboratories Ltd for the company's overall valuation and market capitalisation.
DIVA Laboratories Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how DIVA Laboratories Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
DIVA Laboratories Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DIVA Laboratories Ltd ranked by their cash flow conversion efficiency. Explore how high is DIVA Laboratories Ltd's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Thinkific Labs Inc
TO:THNC
|
-0.004x |
|
TROPHY GAMES Development AS
CO:TGAMES
|
0.145x |
|
Nevada King Gold Corp
V:NKG
|
-0.095x |
|
Grupo Mexicano de Desarrollo S.A.B
MX:GMD
|
0.005x |
|
JLS Co.Ltd
KQ:040420
|
0.043x |
|
Smart Digital Group Limited Ordinary Shares
NASDAQ:SDM
|
N/A |
|
As Commercial Industrial Company of Computers and Toys S.A.
AT:ASCO
|
0.028x |
|
Bak Ambalaj Sanayi ve Ticaret AS
IS:BAKAB
|
0.055x |
Annual Cash Flow Conversion Efficiency for DIVA Laboratories Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of DIVA Laboratories Ltd from 2017 to 2025. View latest DIVA Laboratories Ltd stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$1.03 Billion ≈ $32.42 Million |
NT$20.77 Million ≈ $654.34K |
0.020x | -82.70% |
| 2024-12-31 | NT$1.06 Billion ≈ $33.25 Million |
NT$123.14 Million ≈ $3.88 Million |
0.117x | -52.36% |
| 2023-12-31 | NT$1.03 Billion ≈ $32.54 Million |
NT$252.91 Million ≈ $7.97 Million |
0.245x | +240.01% |
| 2022-12-31 | NT$1.02 Billion ≈ $32.02 Million |
NT$73.19 Million ≈ $2.31 Million |
0.072x | +723.74% |
| 2021-12-31 | NT$986.42 Million ≈ $31.08 Million |
NT$-11.39 Million ≈ $-358.85K |
-0.012x | +31.40% |
| 2020-12-31 | NT$988.89 Million ≈ $31.16 Million |
NT$-16.64 Million ≈ $-524.38K |
-0.017x | -136.22% |
| 2019-12-31 | NT$1.13 Billion ≈ $35.70 Million |
NT$52.66 Million ≈ $1.66 Million |
0.046x | -36.04% |
| 2018-12-31 | NT$1.18 Billion ≈ $37.30 Million |
NT$86.02 Million ≈ $2.71 Million |
0.073x | +41.41% |
| 2017-12-31 | NT$806.75 Million ≈ $25.42 Million |
NT$41.45 Million ≈ $1.31 Million |
0.051x | -- |
About DIVA Laboratories Ltd
DIVA Laboratories, Ltd. engages in the research, development, manufacture, and sale of medical devices and computer peripherals worldwide. The company provides endo/surgical displays for hybrid and other types of OR applications; color and mono displays for radiology applications; and touch and embedded display, as well as industrial displays. DIVA Laboratories, Ltd. was founded in 1984 and is he… Read more